Cargando…

The surgical perspective in precision treatment of diffuse gliomas

Over the last decade, advances in molecular and imaging-based biomarkers have induced a more versatile diagnostic classification and prognostic evaluation of glioma patients. This, in combination with a growing therapeutic armamentarium, enables increasingly individualized, risk-benefit-optimized tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thon, Niklas, Tonn, Joerg-Christian, Kreth, Friedrich-Wilhelm
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390867/ https://www.ncbi.nlm.nih.gov/pubmed/30863116

Ejemplares similares

Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
por: Thon, Niklas, et al.
Publicado: (2013)

Iodine-125 brachytherapy for brain tumours - a review
por: Schwarz, Silke B, et al.
Publicado: (2012)

O(6)-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation
por: Kreth, Simone, et al.
Publicado: (2011)

Diagnostic Yield and Complication Rate of Stereotactic Biopsies in Precision Medicine of Gliomas
por: Katzendobler, Sophie, et al.
Publicado: (2022)

Early treatment of complex located pediatric low‐grade gliomas using iodine‐125 brachytherapy alone or in combination with microsurgery
por: Kunz, Mathias, et al.
Publicado: (2015)

Intronic miR-744 Inhibits Glioblastoma Migration by Functionally Antagonizing Its Host Gene MAP2K4
por: Hübner, Max, et al.
Publicado: (2018)

Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II
por: Karschnia, Philipp, et al.
Publicado: (2020)

Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
por: Quach, Stefanie, et al.
Publicado: (2022)

Subventricular zone involvement is associated with worse outcome in glioma WHO grade 2 depending on molecular markers
por: Karschnia, Philipp, et al.
Publicado: (2021)

Voxel-wise analysis of dynamic (18)F-FET PET: a novel approach for non-invasive glioma characterisation
por: Vomacka, Lena, et al.
Publicado: (2018)

The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicine
por: Katzendobler, Sophie, et al.
Publicado: (2022)

Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas
por: Hadi, Indrawati, et al.
Publicado: (2021)

CAR T-Cells for CNS Lymphoma: Driving into New Terrain?
por: Karschnia, Philipp, et al.
Publicado: (2021)

Frequency and Prognostic Relevance of Volumetric MRI Changes in Contrast- and Non-Contrast-Enhancing Tumor Compartments between Surgery and Radiotherapy of IDHwt Glioblastoma
por: Teske, Nico, et al.
Publicado: (2023)

Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma Recurrences
por: Lietke, Stefanie, et al.
Publicado: (2021)

Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status
por: Weller, Jonathan, et al.
Publicado: (2023)

PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression
por: Weller, Jonathan, et al.
Publicado: (2021)

Expression of Integrin α(v)β(3) in Gliomas Correlates with Tumor Grade and Is not Restricted to Tumor Vasculature
por: Schnell, Oliver, et al.
Publicado: (2008)

Advanced Pediatric Diffuse Pontine Glioma Murine Models Pave the Way towards Precision Medicine
por: Chen, Zirong, et al.
Publicado: (2021)

Immunotherapy approaches for the treatment of diffuse midline gliomas
por: Bernstock, Joshua D., et al.
Publicado: (2022)

(18)F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
por: Weller, Michael, et al.
Publicado: (2020)

Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
por: Teske, Nico, et al.
Publicado: (2021)

A Survey of Radiomics in Precision Diagnosis and Treatment of Adult Gliomas
por: Du, Peng, et al.
Publicado: (2022)

Cancer vaccine strategies for the treatment of diffusely infiltrating gliomas
por: Jucht, Alexander, et al.
Publicado: (2023)

A H3K27M-targeted vaccine in adults with diffuse midline glioma
por: Grassl, Niklas, et al.
Publicado: (2023)

Advanced imaging findings in stroke-like migraine attacks after radiation therapy (SMART) syndrome
por: Teske, Nico, et al.
Publicado: (2022)

Suspected recurrence of brain metastases after focused high dose radiotherapy: can [(18)F]FET- PET overcome diagnostic uncertainties?
por: Romagna, Alexander, et al.
Publicado: (2016)

Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma
por: Blobner, Jens, et al.
Publicado: (2023)

Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
por: Weller, Michael, et al.
Publicado: (2022)

Surgical treatment of diffuse and multi-lobes involved glioma with the assistance of a multimodal technique
por: Liu, Jiayu, et al.
Publicado: (2022)

Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma
por: Pachocki, Casper J., et al.
Publicado: (2022)

Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
por: Weller, Jonathan, et al.
Publicado: (2022)

Liquid biopsies in patients with diffuse glioma
por: Best, Myron G., et al.
Publicado: (2015)

Brain Tumor Networks in Diffuse Glioma
por: Yang, Yvonne, et al.
Publicado: (2022)

TSPO PET signal using [(18)F]GE180 is associated with survival in recurrent gliomas
por: Quach, Stefanie, et al.
Publicado: (2022)

Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium
Publicado: (2018)

The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation
por: Hübner, Max, et al.
Publicado: (2020)

Shunt dependency in supratentorial intraventricular tumors depends on the extent of tumor resection
por: Teske, Nico, et al.
Publicado: (2023)

Pathology and Genetics of Diffuse Gliomas in Adults
por: KOMORI, Takashi
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tf0ncu59kla8tr5e9k7s67g4s5